Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Blagden

Showing results (11-20 of 59) with videos related to

Pageof 6
Sort By:
RNA Biology|March 2, 2021
A decade of LARP societySarah P Blagden, Mark Bayfield, Cecile Bousquet-Antonelli
Psycho-Oncology|May 21, 2019
New challenges in psycho-oncology: Using drug development methodology to improve survivorship and supportive care intervention trialsLesley Howells, Nicholas J Hulbert-Williams, Sarah P Blagden
Cancer Prevention Research (Philadelphia, Pa.)|July 6, 2025
Precision Prevention Studies: A Targeted Approach to Cancer PreventionSarah P Blagden, Kevin W Dodd, Karen Brown, et al.
Expert Opinion on Drug Discovery|March 15, 2013
Targeting cell cycle kinases and kinesins in anticancer drug developmentTimothy A Yap, L Rhoda Molife, Sarah P Blagden, et al.
British Journal of Cancer|September 11, 2003
Performance status score: do patients and their oncologists agree?S P Blagden, S C Charman, L D Sharples, et al.
RNA Biology|April 3, 2020
Controversies around the function of LARP1Andrea J Berman, Carson C Thoreen, Zinaida Dedeic, et al.
British Journal of Cancer|February 22, 2002
The effect of early pregnancy following chemotherapy on disease relapse and foetal outcome in women treated for gestational trophoblastic tumoursS P Blagden, M A Foskett, R A Fisher, et al.
The Lancet. Oncology|March 29, 2023
From the European Medicines Agency to Project Orbis: new activities and challenges to facilitate UK oncology drug approval following BrexitMark P Lythgoe, Jonathan Krell, Mark Bower, et al.
Medical Oncology (Northwood, London, England)|June 13, 2020
NUC-1031, use of ProTide technology to circumvent gemcitabine resistance: current status in clinical trialsZainul Abedin Kapacee, Jennifer J Knox, Daniel Palmer, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|October 16, 2025
Clinical Impact of Next-Generation Sequencing-Guided Targeted Therapies in Advanced Cancer: A Systematic Review and Meta-AnalysisF Kazmi, R Katyal, T F D Liu, et al.
Pageof 6

Showing results (11-20 of 59) with videos related to

Sort By:
Pageof 6
RNA Biology|March 2, 2021
A decade of LARP societySarah P Blagden, Mark Bayfield, Cecile Bousquet-Antonelli
Psycho-Oncology|May 21, 2019
New challenges in psycho-oncology: Using drug development methodology to improve survivorship and supportive care intervention trialsLesley Howells, Nicholas J Hulbert-Williams, Sarah P Blagden
Cancer Prevention Research (Philadelphia, Pa.)|July 6, 2025
Precision Prevention Studies: A Targeted Approach to Cancer PreventionSarah P Blagden, Kevin W Dodd, Karen Brown, et al.
Expert Opinion on Drug Discovery|March 15, 2013
Targeting cell cycle kinases and kinesins in anticancer drug developmentTimothy A Yap, L Rhoda Molife, Sarah P Blagden, et al.
British Journal of Cancer|September 11, 2003
Performance status score: do patients and their oncologists agree?S P Blagden, S C Charman, L D Sharples, et al.
RNA Biology|April 3, 2020
Controversies around the function of LARP1Andrea J Berman, Carson C Thoreen, Zinaida Dedeic, et al.
British Journal of Cancer|February 22, 2002
The effect of early pregnancy following chemotherapy on disease relapse and foetal outcome in women treated for gestational trophoblastic tumoursS P Blagden, M A Foskett, R A Fisher, et al.
The Lancet. Oncology|March 29, 2023
From the European Medicines Agency to Project Orbis: new activities and challenges to facilitate UK oncology drug approval following BrexitMark P Lythgoe, Jonathan Krell, Mark Bower, et al.
Medical Oncology (Northwood, London, England)|June 13, 2020
NUC-1031, use of ProTide technology to circumvent gemcitabine resistance: current status in clinical trialsZainul Abedin Kapacee, Jennifer J Knox, Daniel Palmer, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|October 16, 2025
Clinical Impact of Next-Generation Sequencing-Guided Targeted Therapies in Advanced Cancer: A Systematic Review and Meta-AnalysisF Kazmi, R Katyal, T F D Liu, et al.
Pageof 6